These Unicorns Are Growing The Fastest, Making Them Potential Future Investments
When it comes to unicorns – privately held startup companies valued at $1 billion or more – the author of today’s article remarks that the…
Investor
3 Trends Shaping The Future Of The Biotech Industry – And 3 Biotech Stocks Well Positioned To Outperform
Assessing the current state of the biotech industry, the author of today’s article notes that “While the coronavirus treatments will take center stage in 2021,…
RBC’s Top Digital Health Stocks For Continued Momentum This Year
With the pandemic forcing patients/providers to alter the way they sought/delivered health care, the digital health industry gained momentum last year. In a recent report,…
This Biotech’s Unique Approach To Drug Development Could Give It The Best Chance Of Beating The Market This Year
When it comes to the author of today’s article’s top biotech stock pick for 2021, an under-the-radar name, he explains that “Many of the reasons…
2020: The Year “The Dumb Money Was The Smart Money”
“The dumb money was the smart money this year,” is how one portfolio manager cited in today’s article sums up the wild swings experienced by…
Battle Of The “Strong Buy” Biotechs
BioXcel Therapeutics is a clinical-stage biopharmaceutical company that utilizes artificial intelligence to identify improved therapies in neuroscience and immuno-oncology. TG Therapeutics is a biopharmaceutical company…
3 Biotech Stocks Flying High In The Mid-Cap “Sweet Spot”
In regards to biotech’s bullish year, the author of today’s article notes that “The COVID-19 pandemic has put a fire under many lesser-known names, including…
2 Biotech ETFs To Monitor For Potential Breakouts – And Possible Trading Plays For Both
With the global biotechnology market expected, by one estimate, to almost double from its $448 billion level last year to $833 billion by 2027, today’s…
Biotech Stocks Of Every Kind For Investors Of Every Kind In 2021
From traditional “Big Pharma” stocks that have adopted (or are adopting) a greater focus on biotech to large “pure-play” biotech companies to “emerging” biotech stocks…
A High Risk/High Reward Way To Play The Shift To Biotech Solutions
When it comes to treating diseases, the author of today’s article notes “It seems that there is a shift away from treating symptoms with chemical…